Goldman Sachs Downgrades Gentex to Sell on Margin Concerns

Goldman Sachs has downgraded Gentex (ISIN: US3719011096) from Neutral to Sell and reduced its price target from USD 23.00 to USD 20.00 in a research note dated October 5, 2026. The firm cited margin pressure as the primary reason behind the downgrade, highlighting rising memory and electronics costs as risks to Gentex's margins in the near to medium term. Goldman Sachs also noted that Gentex has the lowest exposure to Chinese domestic original equipment manufacturers in its tier-one coverage, which could complicate the customer-weighted light-vehicle production environment if Chinese automakers continue gaining market share.

In its report, Goldman Sachs put its 2027 earnings-per-share estimate 7.00 percent below FactSet consensus, indicating that the lower price target reflects a projected earnings constraint rather than just a valuation adjustment. Gentex's second-quarter 2026 results showed USD 651.3 million in revenue, which was below the USD 668.2 million consensus estimate and represented a 1.00 percent year-over-year decline. However, adjusted earnings per share reached USD 0.58, surpassing the USD 0.50 consensus estimate, and the gross margin improved to 37.00 percent from 34.20 percent in the same quarter of 2025.

Gentex maintained its full-year revenue guidance, raised its gross-margin outlook, and reduced spending plans, according to Investing.com. The company is set to release its third-quarter 2026 financial results on October 23, 2026, before the market opens, with a conference call scheduled for 9:30 a.m. ET. As of October 6, 2026, Gentex stock was trading at EUR 19.13 at Lang & Schwarz, down 2.00 percent from the prior close of EUR 19.52. The US primary listing is on Nasdaq, where the market capitalization was USD 4.7 billion as of October 5, 2026, with a 52-week range of USD 20.48 to USD 27.40.